Evidence of basal pituitary–adrenal overactivity in first episode, drug naïve patients with schizophrenia
- 16 December 2003
- journal article
- clinical trial
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 29 (8) , 1065-1070
- https://doi.org/10.1016/j.psyneuen.2003.08.011
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Stress and the progression of the developmental hypothesis of schizophreniaThe British Journal of Psychiatry, 2002
- Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent mannerPublished by Elsevier ,2002
- Vasopressinergic regulation of the hypothalamic–pituitary–adrenal axis: implications for stress adaptationRegulatory Peptides, 2000
- Effect of Acute Metabolic Stress on Pituitary-Adrenal Axis Activation in Patients With SchizophreniaAmerican Journal of Psychiatry, 1998
- Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect.Endocrinology, 1995
- Vasopressinergic Control of Pituitary Adrenocorticotropin Secretion Comes of AgeFrontiers in Neuroendocrinology, 1993
- The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patientsLife Sciences, 1992
- CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophreniaAmerican Journal of Psychiatry, 1987
- Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjectsPsychopharmacology, 1986
- Abnormal dexamethasone suppression test results in chronic schizophrenic patientsAmerican Journal of Psychiatry, 1982